<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medsovet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский Совет</journal-title><trans-title-group xml:lang="en"><trans-title>Meditsinskiy sovet = Medical Council</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2079-701X</issn><issn pub-type="epub">2658-5790</issn><publisher><publisher-name>REMEDIUM GROUP Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/2079-701X-2014-1-62-67</article-id><article-id custom-type="elpub" pub-id-type="custom">medsovet-1224</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Рациональная фармакотерапия</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Rational pharmacotherapy</subject></subj-group></article-categories><title-group><article-title>Рациональная антибактериальная терапия инфекций дыхательных путей</article-title><trans-title-group xml:lang="en"><trans-title>Rational antibiotic therapy of respiratory infections</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Таточенко</surname><given-names>В. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Tatochenko</surname><given-names>VK</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бакрадзе</surname><given-names>М. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Bakradze</surname><given-names>MD</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хохлова</surname><given-names>Т. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Khokhlova</surname><given-names>TA</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рогова</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Rogova</surname><given-names>OA</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное учреждение «Научный центр здоровья детей» РАМН</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Scientific Center of Children's Health RAMS, department of diagnostics and rehabilitation treatment, Moscow</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>30</day><month>12</month><year>2014</year></pub-date><volume>0</volume><issue>1</issue><fpage>62</fpage><lpage>67</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Таточенко В.К., Бакрадзе М.Д., Хохлова Т.А., Рогова О.А., 2014</copyright-statement><copyright-year>2014</copyright-year><copyright-holder xml:lang="ru">Таточенко В.К., Бакрадзе М.Д., Хохлова Т.А., Рогова О.А.</copyright-holder><copyright-holder xml:lang="en">Tatochenko V., Bakradze M., Khokhlova T., Rogova O.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-sovet.pro/jour/article/view/1224">https://www.med-sovet.pro/jour/article/view/1224</self-uri><trans-abstract xml:lang="en"><p>Respiratory infections are among the most common diseases of childhood and the main reason for seeking medical help. Most of them are known to be viral; however, a big role among upper and lower respiratory tract infections belongs to those caused by pathogens such as pneumococci, Haemophilus influenzae and pyogenic streptococci. Despite the availability of international guidelines and medical literature on antimicrobial chemotherapy, the percentage of unjustified antibiotic therapies remains high, leading to enhanced resistance of pathogens.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>резистентность</kwd><kwd>пневмококк</kwd><kwd>амоксициллин</kwd><kwd>амоксициллин/клавуланат</kwd><kwd>джозамицин</kwd><kwd>resistance</kwd><kwd>pneumococcus</kwd><kwd>amoxicillin</kwd><kwd>amoxicillin/clavulanate</kwd><kwd>josamycin</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Баранов А.А. Клинические рекомендации по педиатрии. 2-е изд. М.: Гэотар-Медиа, 2009.</mixed-citation><mixed-citation xml:lang="en">Баранов А.А. Клинические рекомендации по педиатрии. 2-е изд. М.: Гэотар-Медиа, 2009.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Рязанцев С.В., Кочеровец В.И., Молчанова М.В. Лечение острого гнойного синусита у детей макролидами. Consilium medicum, 2009;3.</mixed-citation><mixed-citation xml:lang="en">Рязанцев С.В., Кочеровец В.И., Молчанова М.В. Лечение острого гнойного синусита у детей макролидами. Consilium medicum, 2009;3.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Brook I. Sinusitis. From microbiology to management. New York. Taylor&amp;Francis, 2006.</mixed-citation><mixed-citation xml:lang="en">Brook I. Sinusitis. From microbiology to management. New York. Taylor&amp;Francis, 2006.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Дарманян А.С. Совершенствование методов диагностики и лечения острых тонзиллитов у детей. Автореф. дис. ... канд. мед. наук. М., 2010.</mixed-citation><mixed-citation xml:lang="en">Дарманян А.С. Совершенствование методов диагностики и лечения острых тонзиллитов у детей. Автореф. дис. ... канд. мед. наук. М., 2010.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Defilippi A, Silvestri M, Tacchella A et al. Epidemiology and clinical features of Mycoplasma pneumoniae in chjldren. Respir Med, 2008;102(12):1762-1768.</mixed-citation><mixed-citation xml:lang="en">Defilippi A, Silvestri M, Tacchella A et al. Epidemiology and clinical features of Mycoplasma pneumoniae in chjldren. Respir Med, 2008;102(12):1762-1768.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Таточенко В.К. Болезни органов дыхания у детей. Практическое руководство. М.: «ПедиатрЪ», 2012.</mixed-citation><mixed-citation xml:lang="en">Таточенко В.К. Болезни органов дыхания у детей. Практическое руководство. М.: «ПедиатрЪ», 2012.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Bamba M, Jozaki K, Sugaya N et al. Prospective surveillance for atypical pathogens in children with commu-nity-acquared pneumonia in Japan. Infect Chemother, 2006;12(1):36-41.</mixed-citation><mixed-citation xml:lang="en">Bamba M, Jozaki K, Sugaya N et al. Prospective surveillance for atypical pathogens in children with commu-nity-acquared pneumonia in Japan. Infect Chemother, 2006;12(1):36-41.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Козлов РС. [и др.]. ПеГАС 1999-2009, КМАХ. Т. 12-4-319-331.</mixed-citation><mixed-citation xml:lang="en">Козлов РС. [и др.]. ПеГАС 1999-2009, КМАХ. Т. 12-4-319-331.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Felmigham D, Reinert RR, Hirakata Y et al. Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and comparative in vitro activity of the ketolide, telithromycin. J. Antimicrob Chemother, 2002;50(Suppl. S1):25-37.</mixed-citation><mixed-citation xml:lang="en">Felmigham D, Reinert RR, Hirakata Y et al. Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and comparative in vitro activity of the ketolide, telithromycin. J. Antimicrob Chemother, 2002;50(Suppl. S1):25-37.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Жаркова Л.П. Устное сообщение. 2012.</mixed-citation><mixed-citation xml:lang="en">Жаркова Л.П. Устное сообщение. 2012.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">European centre for disease prevention and control. Antimicrobial resistance surveillance in Europe 2012:5158.</mixed-citation><mixed-citation xml:lang="en">European centre for disease prevention and control. Antimicrobial resistance surveillance in Europe 2012:5158.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Козлов Р.С., Сивая О.В., Кречикова О.И., Иванчик Н.В. Динамика резистентности Streptococcus pneumoniae к антибиотикам в России за период 1999-2009 гг. Клиническая микробиология и антимикробная химиотерапия, 2010:12-24, 1-13.</mixed-citation><mixed-citation xml:lang="en">Козлов Р.С., Сивая О.В., Кречикова О.И., Иванчик Н.В. Динамика резистентности Streptococcus pneumoniae к антибиотикам в России за период 1999-2009 гг. Клиническая микробиология и антимикробная химиотерапия, 2010:12-24, 1-13.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Сидоренко С.В., Грудинина С.А., Филимонова О.Ю., Столярова Л.Г, Савинова С.А. Резистентность к макролидам и линкозамидам среди Streptococcus pneumoniae и Streptococcus pyogenes в РФ. Клиническая фармакология и терапия, 2008:17-2, 1-4</mixed-citation><mixed-citation xml:lang="en">Сидоренко С.В., Грудинина С.А., Филимонова О.Ю., Столярова Л.Г, Савинова С.А. Резистентность к макролидам и линкозамидам среди Streptococcus pneumoniae и Streptococcus pyogenes в РФ. Клиническая фармакология и терапия, 2008:17-2, 1-4</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Сивая О.В. Устное сообщение. 2012.</mixed-citation><mixed-citation xml:lang="en">Сивая О.В. Устное сообщение. 2012.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Гаращенко Т.И. Макролиды в терапии острого тонзиллита и его осложнения у детей. РМЖ, 2001;9(19).</mixed-citation><mixed-citation xml:lang="en">Гаращенко Т.И. Макролиды в терапии острого тонзиллита и его осложнения у детей. РМЖ, 2001;9(19).</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Всемирная организация здравоохранения. Оказание стационарной помощи детям. Карманный справочник.</mixed-citation><mixed-citation xml:lang="en">Всемирная организация здравоохранения. Оказание стационарной помощи детям. Карманный справочник.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Harris M, Clark J, Coote N, Fletcher P, Harnden A, McKean M, Thomson A. Guidelines for the management of community acquired pneumonia in children: update 2011. Thorax, 2011:66-2.</mixed-citation><mixed-citation xml:lang="en">Harris M, Clark J, Coote N, Fletcher P, Harnden A, McKean M, Thomson A. Guidelines for the management of community acquired pneumonia in children: update 2011. Thorax, 2011:66-2.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">John S. Bradley, Carrie L. Byington, Samir S. Shah, Brian Alverson, Edward R. Carter, Christopher Harrison, Sheldon L. Kaplan, Sharon E. Mace, George H. McCracken Jr, Matthew R. Moore, Shawn D. St Peter, Jana A. Stockwell, Jack T. Swanson The Management of Community-Acquired. Pneumonia in Infants and Children Older Than Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. 2011.</mixed-citation><mixed-citation xml:lang="en">John S. Bradley, Carrie L. Byington, Samir S. Shah, Brian Alverson, Edward R. Carter, Christopher Harrison, Sheldon L. Kaplan, Sharon E. Mace, George H. McCracken Jr, Matthew R. Moore, Shawn D. St Peter, Jana A. Stockwell, Jack T. Swanson The Management of Community-Acquired. Pneumonia in Infants and Children Older Than Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. 2011.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Баранов А.А., Таточенко В.К., Бакрадзе М.Д. Лихорадочные синдромы у детей. Рекомендации по диагностике и лечению. Союз педиатров России. М., 2011.</mixed-citation><mixed-citation xml:lang="en">Баранов А.А., Таточенко В.К., Бакрадзе М.Д. Лихорадочные синдромы у детей. Рекомендации по диагностике и лечению. Союз педиатров России. М., 2011.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Cochrane Database of Systematic Reviews. Comparing different durations of the same antibiotic therapy for non-severe community-acquired pneumonia in children under five years of age. 2008</mixed-citation><mixed-citation xml:lang="en">Cochrane Database of Systematic Reviews. Comparing different durations of the same antibiotic therapy for non-severe community-acquired pneumonia in children under five years of age. 2008</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Таточенко В.К. Джозамицин в педиатрической практике. Педиатрия, 2011;90(5)125-128.</mixed-citation><mixed-citation xml:lang="en">Таточенко В.К. Джозамицин в педиатрической практике. Педиатрия, 2011;90(5)125-128.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Таточенко В.К., Бакрадзе М.Д., Дарманян А.С. Острые тонзиллиты в детском возрасте: диагностика и лечение. Актуальные вопросы педиатрии, 2009;5(27).</mixed-citation><mixed-citation xml:lang="en">Таточенко В.К., Бакрадзе М.Д., Дарманян А.С. Острые тонзиллиты в детском возрасте: диагностика и лечение. Актуальные вопросы педиатрии, 2009;5(27).</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Treatment of acute group A beta1hemolytic streptococcal tonsillitis in children with a 51day course of josa-mycin. Portier H, Bourrillon A, Lucht F [et al.]. Arch Pediatr, 2001;8(7):700-6.</mixed-citation><mixed-citation xml:lang="en">Treatment of acute group A beta1hemolytic streptococcal tonsillitis in children with a 51day course of josa-mycin. Portier H, Bourrillon A, Lucht F [et al.]. Arch Pediatr, 2001;8(7):700-6.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Кречиков В.А., Катосова Л.К., Копытко Л.Н., Розанова С.М., Шилова В.П., Кречикова О.И., Иванчик Н.В., Козлов С.Н. Сравнение микробиологической эффективности 7- и 10-дневного курса джозамицина при остром стрептококковом тонзиллофарингите у детей: предварительные результаты Российского многоцентрового исследования. Клиническая микробиология и антимикробная химиотерапия. 2009;11(2):21.</mixed-citation><mixed-citation xml:lang="en">Кречиков В.А., Катосова Л.К., Копытко Л.Н., Розанова С.М., Шилова В.П., Кречикова О.И., Иванчик Н.В., Козлов С.Н. Сравнение микробиологической эффективности 7- и 10-дневного курса джозамицина при остром стрептококковом тонзиллофарингите у детей: предварительные результаты Российского многоцентрового исследования. Клиническая микробиология и антимикробная химиотерапия. 2009;11(2):21.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Ушкалова Е. Значение лекарственных форм для рациональной антибиотикотерапии. Лекарственная форма солютаб. Врач, 2007;3:1-4.</mixed-citation><mixed-citation xml:lang="en">Ушкалова Е. Значение лекарственных форм для рациональной антибиотикотерапии. Лекарственная форма солютаб. Врач, 2007;3:1-4.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
